sPLA2-IIa and Coronary Heart Disease
Author Information
Author(s): Breitling Lutz P., Koenig Wolfgang, Fischer Marcus, Mallat Ziad, Hengstenberg Christian, Rothenbacher Dietrich, Brenner Hermann
Primary Institution: German Cancer Research Center (DKFZ), Heidelberg, Germany
Hypothesis
Is the association of sPLA2-IIa with secondary cardiovascular disease events causal or confounded by other risk markers?
Conclusion
The findings suggest a causal relationship between genetic polymorphisms affecting sPLA2-IIa levels and prognosis in cardiovascular disease patients.
Supporting Evidence
- Genetic polymorphisms in PLA2G2A were associated with serum sPLA2-IIa concentrations.
- An increase in sPLA2-IIa levels was linked to a higher risk of secondary cardiovascular events.
- The study included a large cohort with a median follow-up of 8 years.
Takeaway
This study looked at a protein called sPLA2-IIa to see if it really causes heart problems or if other factors are just making it look that way.
Methodology
The study analyzed eight-year follow-up data from a cohort of patients who underwent rehabilitation after a cardiovascular event, examining genetic polymorphisms and their association with serum sPLA2-IIa levels and cardiovascular events.
Potential Biases
Possible selection bias due to genotypes associated with higher risk for primary manifestations.
Limitations
Moderate statistical power and potential self-selection bias due to voluntary participation.
Participant Demographics
Median age of 61 years, 85.1% male, 58.3% had suffered an acute myocardial infarction.
Statistical Information
P-Value
0.0057
Confidence Interval
1.09–1.63
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website